ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "imaging techniques"

  • Abstract Number: 2350 • 2012 ACR/ARHP Annual Meeting

    Similarities Exceeds Differences in the Pattern of Joint and Vascular Positron Emission/Computed Tomography Uptake in Polymyalgia Rheumatica and Giant Cell Arteritis

    Dario Camellino1, Silvia Morbelli2, Francesco Paparo3, Michela Massollo2, Gianmario Sambuceti4 and Marco A. Cimmino5, 1Dipartimento Medicina Interna, Clinica Reumatologica, Genova, Italy, 2Dipartimento Medicina Interna, Medicina Nucleare, Genova, Italy, 3Radiology Unit, E.O. Ospedali Galliera, Genoa, Italy, 4Dipartimento di Medicina Interna, Medicina Nucleare, Genova, Italy, 5Department of Internal Medicine, Academic Unit of Clinical Rheumatology, University of Genova, Genova, Italy

    Background/Purpose: Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are two frequent overlapping diseases. The purpose of this work is to examine the relationship between…
  • Abstract Number: 1486 • 2012 ACR/ARHP Annual Meeting

    Poor Outcome in Patients with Systemic Sclerosis and Myocardial Involvement: A Combined Approach Based On Clinical and Laboratory Findings, EKG-Holter and Cardiac Magnetic Resonance

    Silvia Laura Bosello, Giacomo De Luca, Antonella Laria, Giorgia Berardi and Gianfranco Ferraccioli, Division of Rheumatology, Institute of Rheumatology and Affine Sciences, Catholic University of the Sacred Heart, Rome, Italy

    Background/Purpose: Cardiac involvement is a relevant prognostic determinant in Systemic Sclerosis (SSc), but the diagnosis is often delayed due to the lack of a specific…
  • Abstract Number: 1119 • 2012 ACR/ARHP Annual Meeting

    Prediction of MRI-Detected Cartilage Loss Over 30 Months Using Simplified Radiographic and Clinical Stratification: The MOST Study

    Frank Roemer1, David T. Felson2, Jingbo Niu3, Yuqing Zhang2, Michael C. Nevitt4, Michel Crema5, Cora E. Lewis6, James Torner7 and Ali Guermazi5, 1Klinikum Augsburg, Augsburg, Germany, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 4Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 5Boston University, Boston, MA, 6Preventive Medicine, University of Alabama, Birmingham, Birmingham, AL, 7Epidemiology, University of Iowa, Iowa City, Iowa City, IA

    Background/Purpose: MRI-detected cartilage loss is the main structural outcome measure in large studies of knee OA. Definition of subjects at high risk for cartilage loss…
  • Abstract Number: 1042 • 2012 ACR/ARHP Annual Meeting

    Psoriatic Arthritis Patients Assessed by Dynamic Contrast-Enhanced MRI in High Disease Versus Minimal Disease Activity State – a Cross-Sectional Study Correlating Conventional MRI and Clinical Composite Measures

    René Panduro Poggenborg1, Pernille Bøyesen2, Charlotte Wiell3, Susanne Juhl Pedersen4, Inge Juul Sørensen5, Ole Rintek Madsen6, Ole Slot1, Jakob M. Møller7, Mikael Boesen8, Henning Bliddal9, Olga Kubassova10 and Mikkel Østergaard11, 1Department of Rheumatology, Copenhagen University Hospital in Glostrup, Copenhagen, Denmark, 2Rheumatology, Diakonhjemmet Hospital, Olso, Norway, 3Department of Rheumatology, Copenhagen University Hospital in Gentofte, Copenhagen, Denmark, 4Department of Rheumatology, Copenhagen University Hospital Glostrup, Copenhagen, Denmark, 5Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, 6DANBIO, On behalf of Depts of Rheumatology, North, South, Central, Zealand and Capital Region, Copenhagen, Denmark, 7Department of Radiology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark, 8The Parker Institute, Department of Rheumatology, Copenhagen University Hospital at Frederiksberg, Copenhagen, Denmark, 9The Parker Institute, Department of Rheumatology, Copenhagen University Hospital at Frederiksberg, Frederiksberg, Denmark, 10Image Analysis Ltd., Leeds, United Kingdom, 11Dept of Rheumatology RM, Glostrup Hospital, Glostrup, Denmark

    Background/Purpose: Dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) has been validated in rheumatoid arthritis for measuring inflammation, but has rarely been studied in psoriatic arthritis…
  • Abstract Number: 1050 • 2012 ACR/ARHP Annual Meeting

    Assessment of Validity of Magnetic Resonance Imaging Measures of Joint Inflammation and Damage in Rheumatoid Arthritis Wrist/Hand – a Systematic Literature Review

    TG Woodworth1, O. Morgacheva2, OM Troum3, OL Pimienta4, P. Maranian5, V.K. Ranganath5 and Daniel Furst5, 1Medicine, Division of Rheumatology, David Geffen School of Medicine, University of California, Los Angeles, CA, 2Medicine/Division of Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA, 3Medicine, USC Keck School of Medicine, Santa Monica, CA, 4Keck School of Medicine, University of Southern California, Los Angeles, CA, 5Medicine, Division of Rheumatology, David Geffen School of Medicine, UCLA, Los Angeles, CA

    Background/Purpose: Limitation of x-ray joint damage is a key indicator of therapeutic efficacy in rheumatoid arthritis (RA). Although magnetic resonance imaging (MRI) is increasingly used…
  • Abstract Number: 1019 • 2012 ACR/ARHP Annual Meeting

    Visualization of Cartilage in High-Resolution Magnetic Resonance Imaging Is a New Imaging Biomarker for the Quantification of Joint Damage in Rheumatoid Arthritis

    Barbara Herz1, Stephanie Finzel1, Andreas Albrecht1, Juergen Rech2, Matthias Englbrecht1, Goetz Welsch3 and Georg Schett1, 1Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 3Department of Traumatic Surgery, Department of Traumatic Surgery, University Clinic of Erlangen-Nuremberg, Erlangen, Germany, Erlangen, Germany

    Background/Purpose: Recent achievements in Magnetic Resonance Imaging (MRI) have been the gradient-echo-based T1-delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) focussing on the detection of proteoglycan content…
  • Abstract Number: 1021 • 2012 ACR/ARHP Annual Meeting

    Magnetic Resonance Imaging in Follow-up of Clinical Remission in Juvenile Idiopathic Arthritis

    Mira van Veenendaal1, Robert Hemke2, Marjolein I. Bos3, Mario Maas4, Marion A. J. Van Rossum3 and Taco W. Kuijpers5, 1Departments of Pediatric Rheumatology, Emma Children's Hospital / Academic Medical Center (AMC), Amsterdam, Netherlands, 2Departments of Radiology, Academic Medical Center (AMC), Amsterdam, Netherlands, 3Department of Pediatric Rheumatology and Immunology, Emma Children's Hospital / Academic Medical Center (AMC), Amsterdam, Netherlands, 4Radiology, Academic Medical Center, Amsterdam, Netherlands, 5Pediatric Rheumatology and Immunology, Emma Children's Hospital/Academic Medical Center (AMC), Amsterdam, Netherlands

    Background/Purpose: Despite clinical remission, a substantial proportion of Juvenile Idiopathic Arthritis (JIA) patients will flare after a period of inactive disease. MRI has proven to…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology